ClinicalTrials.Veeva

Menu

Preterm Birth and Biomarkers for Cardiovascular Disease (BIO-PRETERM)

U

Uppsala University

Status

Completed

Conditions

Cardiovascular Diseases
Preterm Birth

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Preterm birth is associated with maternal increased risk of cardiovascular disease later in life. In an observational case- control study, investigators want to evaluate whether women with preterm birth have increased levels of biomarkers for cardiovascular disease, to reveal potential pathophysiological mechanisms in common.

Full description

Women with spontaneous preterm birth in first pregnancy and a group of matched controls with spontaneous birth in normal time where invited to participate in the study. Participants were identified from the Biobank of Pregnant Women in Uppsala. Levels of cardiovascular biomarkers will be analyzed in plasma samples from the pregnancy and at a follow-up visit where investigators also collect information about other cardiovascular risk factors and lipid status.

Enrollment

65 patients

Sex

Female

Ages

Under 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women identified as cases or controls

Exclusion criteria

  • System inflammatory disease
  • Smoking at the time of the pregnancy

Trial design

65 participants in 2 patient groups

Preterm birth
Description:
Women with spontaneous preterm birth in first pregnancy
Treatment:
Other: No intervention
Controls
Description:
Matched controls with spontaneous delivery in normal time in first pregnancy
Treatment:
Other: No intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems